Clinical Trials in Phoenix

Showing 5321-5340 of 16,646 trials

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

NCT05500508

A Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patients.

CancerSolid TumorSolid Carcinoma+17 more

Aminex Therapeutics, Inc.15 participantsStarted Nov 2022

Phoenix, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States +4 more locations

RECRUITINGPhase 3< 1 mile

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

NCT05184335

This study is to evaluate the effect and safety of Brilaroxazine in patients with acute schizophrenia compared to the placebo short and long-term. Brilaroxazine will be given at fixed doses of 15 mg or 50 mg once daily over 4 weeks, then in the long-term flexible doses 15-50mg daily over a period of 52 weeks.

Schizophrenia

Reviva Pharmaceuticals690 participantsStarted Jan 2022

Phoenix, Arizona, United States • Bentonville, Arkansas, United States • Little Rock, Arkansas, United States +15 more locations

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Find Trials by Condition in Phoenix

MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis

To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients

Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab

A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease

A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

CYPRESS Efficacy and Safety Study Extension

Oral ONC201 in Adult Recurrent Glioblastoma

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia

Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication

Global Fenestrated Anaconda Clinical STudy